A Randomized Study to Evaluate The Efficacy of Mycophenolate Mofetil Added to The Systemic Immunosuppressive Regimen First Used For Treatment of Chronic Graft-Versus-Host Disease.

Trial Profile

A Randomized Study to Evaluate The Efficacy of Mycophenolate Mofetil Added to The Systemic Immunosuppressive Regimen First Used For Treatment of Chronic Graft-Versus-Host Disease.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Mar 2013

At a glance

  • Drugs Mycophenolate mofetil (Primary)
  • Indications Graft-versus-host disease
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 05 Aug 2009 Status changed from active, no longer recruiting to completed.
    • 21 May 2009 Primary endpoint 'Clinical response' has not been met.
    • 21 May 2009 Status change from active, no longer recruiting to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top